Paxlovid, Pfizer’s anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022.
Wolfgang Rattay | Reuters
The National Institutes of Health said Monday it potential therapies for long Covid”>launched mid-stage clinical trials to test at least four treatments, including Pfizer’s antiviral Covid-19 pill Paxlovid, as potential therapies for long Covid.
There is no proven treatment for the condition, which refers to symptoms that continue or develop in the weeks or months following an initial Covid infection. It affects an estimated 23 million Americans.
related investing news
Health-care providers typically try to treat the often debilitating symptoms associated with long Covid, such as chronic pain, memory loss and intense fatigue. But the lack of a specific long Covid treatment pushes some patients to seek unproven – and potentially dangerous – remedies for the condition.
“We know that when patients are suffering, we can never move fast enough,”…
2023-07-31 13:59:22
Original from www.cnbc.com
rnrn
